NDRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NDRA is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to allocate. The stock is trading below the previous close with weak near-term momentum, no strong proprietary buy signal, and news that adds merger-related uncertainty rather than clarity. Given the lack of supportive financial data, neutral hedge/insider activity, and no visible Wall Street upgrade momentum, the better call is to avoid buying now.
The current price is 4.45, down 6.35% during regular trading versus the previous close of 4.72, showing immediate downside pressure. RSI_6 at 43.84 is neutral, so the stock is not oversold enough to suggest an attractive bounce setup. MACD histogram is slightly positive at 0.00894 but is contracting, which weakens the bullish case and suggests momentum is fading. Moving averages are converging, indicating a lack of strong trend direction. Key support is near 3.95, while resistance starts at 5.12 and then 6.29; with price below pivot, the short-term trend remains soft. The pattern-based forecast also leans negative for the next day and month.
Potential merger-related event activity could create occasional speculative trading interest. The stock remains above the lower support zone, which may offer some stabilization if sentiment improves. AI Stock Picker: no signal on given stock today. SwingMax: No signal on given stock recently.
News around the ENDRA-Noble Africa merger is under scrutiny, with reported concerns that ordinary shareholders may receive only a small ownership stake in the combined company. This creates a negative sentiment backdrop and possible uncertainty around deal value. Hedge funds are neutral, insiders are neutral, and there is no recent congress trading data suggesting influential buying support. Short-term pattern analysis points to a likely decline next day and weak follow-through over the month.
No usable latest-quarter financial snapshot was provided because the financial data returned an error. As a result, there is no reliable evidence here of strong revenue or earnings growth to support a long-term buy decision.
No analyst rating or price target trend data was provided. Based on the available information, Wall Street appears mixed-to-negative rather than supportive: there is no visible upgrade cycle, no strong price target optimism, and the merger scrutiny/news flow outweighs any positive analyst-style sentiment.
